Identification of Antifungal H + -ATPase Inhibitors with Effect on Plasma Membrane Potential
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The plasma membrane H + -ATPase (Pma1) is an essential fungal protein and a proposed target for new antifungal medications. The compounds in a small-molecule library containing ∼191,000 commercially available compounds were screened for their ability to inhibit Saccharomyces cerevisiae plasma membranes containing Pma1. The overall hit rate was 0.2%, corresponding to 407 compounds. These hit compounds were further evaluated for ATPase selectivity and broad-spectrum antifungal activity. Following this work, one Pma1 inhibitor series based on compound 14 and analogs was selected for further evaluation. This compound series was able to depolarize the membrane and inhibit extracellular acidification in intact fungal cells concomitantly with a significant increase in intracellular ATP levels. Collectively, we suggest that these effects may be a common feature of Pma1 inhibitors. Additionally, the work uncovered a dual mechanism for the previously identified cationic peptide BM2, revealing fungal membrane disruption, in addition to Pma1 inhibition. The methods presented here provide a solid platform for the evaluation of Pma1-specific inhibitors in a drug development setting. The present inhibitors could serve as a starting point for the development of new antifungal agents with a novel mode of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comparable ATP accumulation and mitochondrial participation have been reported in C. albicans exposed to hLf, defensins, the BM2 peptide, and pharmacological inhibitors of Pma1 [27,28,30,31,37].”
From Ovotransferrin and Its γ-Core-Containing Peptides Impair Pma1-Dependent Proton Homeostasis in Candida albicans (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A simple cell-based phenotype characterized by plasma membrane depolarization, intracellular ATP accumulation, and defective glucose-induced extracellular acidification has been proposed as a functional signature of impaired Pma1-dependent proton extrusion and used as a screening approach to identify antifungal agents that inhibit Pma1 activity [37].”
From Ovotransferrin and Its γ-Core-Containing Peptides Impair Pma1-Dependent Proton Homeostasis in Candida albicans (2026) · cites this paper as [37]
The cited source says what the claim attributes to it.
In the citing paper
“This supports the idea that this phenotype is not simply a nonspecific consequence of cell death, but rather a reproducible signature of impaired proton homeostasis [37].”
From Ovotransferrin and Its γ-Core-Containing Peptides Impair Pma1-Dependent Proton Homeostasis in Candida albicans (2026) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · cited 1×
“Invasive fungal infections are less common but of much greater concern because they are associated with extremely high mortality rates (20 to 90%) (2).”
BackgroundA Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042 · cited 2×
“False-positive hits may also result from unspecific protein inhibition activity in a homogeneous assay setup (20, 21).”
BackgroundSerrano, R., Kielland-Brandt, M. C., & Fink, G. R. (1986) · Nature · doi:10.1038/319689a0 · Cited by 813 · cited 1×
“The proton pump is essential for fungal growth, as shown by knockout studies (7).”
BackgroundLingrel, J. B., & Kuntzweiler, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32067-7 · Cited by 744
The proton-translocating ATPase of the fungal plasma membrane
Goffeau, A., & Slayman, C. W. (1981) · Biochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics · doi:10.1016/0304-4173(81)90010-0 · Cited by 493
An insight into the antifungal pipeline: selected new molecules and beyond
Ostrosky-Zeichner, L., Casadevall, A., Galgiani, J. N., Odds, F. C., & Rex, J. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3074 · Cited by 432 · cited 8×
“cerevisiae cells exposed to compound 14 yielded an elevated DiBAC4(3) signal after 5 min of exposure, while only a minimal increase of the PI signal was observed (Fig.”
BackgroundMethodInfluentialFoxman, B., Muraglia, R., Dietz, J.-P., Sobel, J. D., & Wagner, J. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318273e8cf · Cited by 261 · cited 1×
“In a survey of women (age 16 years and older, n 6,000), up to 49% had been diagnosed with vulvovaginal candidiasis (VVC), depending upon their ethnic origin, and approximately 20% of those women experienced recurrent VVC in a 12-month follow-up period (1), with a pronounced impact on quality of life.”
BackgroundThe early research and development of ebselen
Parnham, M. J., & Sies, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.028 · Cited by 229 · cited 1×
“several enzymes and modify a range of biological activities (15).”
BackgroundBiological assay challenges from compound solubility: strategies for bioassay optimization
Di, L., & Kerns, E. H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.03.004 · Cited by 181 · cited 2×
“False-positive hits may also result from unspecific protein inhibition activity in a homogeneous assay setup (20, 21).”
BackgroundGradmann, D., Hansen, U., Long, W. S., Slayman, C. L., & Warncke, J. (1978) · The Journal of Membrane Biology · doi:10.1007/bf01869898 · Cited by 166 · cited 1×
“It has been measured to be 175 mV within the fungal species Neurospora crassa (19).”
BackgroundThe antifungal activity and membrane-disruptive action of dioscin extracted from Dioscorea nipponica
Cho, J., Choi, H., Lee, J., Kim, M.-S., Sohn, H.-Y., & Lee, D. G. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.12.010 · Cited by 137 · cited 1×
“Previously, DiBAC4(3) (30) and other fluorescent probes used to measure membrane potential, such as 3,3-dipropylthiacarbocyanide iodide) [diS-C3(3)] (31), have been used to estimate changes in membrane potential.”
Andersen, J. P., Lassen, K. S., & MØLLER, J. V. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89742-3 · Cited by 105
Large-scale preparation of sodium-potassium ATPase from kidney outer medulla
Kłodos, I., Esmann, M., & Post, R. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00654.x · Cited by 91
Regulation of Glycolytic Oscillations by Mitochondrial and Plasma Membrane H+-ATPases
Olsen, L. F., Andersen, A. Z., Lunding, A., Brasen, J. C., & Poulsen, A. K. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.02.026 · Cited by 90 · cited 2×
“Both omeprazole and lactoferrin are described to be Pma1 inhibitors, although omeprazole is not fully capable of inhibiting extracellular acidification (33).”
BackgroundMonk, B. C., Mason, A. B., Abramochkin, G., Haber, J. E., Seto‐Young, D., & Perlin, D. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00133-n · Cited by 78 · cited 3×
“alter the growth-inhibitory effects of omeprazole (4).”
BackgroundInfluentialBeauvoit, B., Rigoulet, M., Raffard, G., Canioni, P., & Guerin, B. (1991) · Biochemistry · doi:10.1021/bi00111a004 · Cited by 69 · cited 1×
“CCCP has previously been shown to affect the mitochondrial membrane and, thereby, the supply of ATP (32).”
BackgroundExploring an antifungal target in the plasma membrane H+-ATPase of fungi
Seto‐Young, D., Monk, B. C., Mason, A. B., & Perlin, D. S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00028-x · Cited by 68
Monk, B. C., Niimi, K., Lin, S., Knight, A., Kardos, T. B., Cannon, R. D., Parshot, R., King, A., Lun, D., & Harding, D. R. K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.57-70.2005 · Cited by 66 · cited 3×
“Special attention should be paid to possible membrane interactions, as BM2 affects fungal membrane integrity and has previously been linked to low-level hemolysis and detectable toxicity in HEp-2 cells (10).”
BackgroundResultInfluentialTransport of Small Ions and Molecules through the Plasma Membrane of Filamentous Fungi
Burgstaller, W. (1997) · Critical Reviews in Microbiology · doi:10.3109/10408419709115129 · Cited by 65 · cited 1×
“We suggest that an increased iATP level is attributable to Pma1 inhibition, considering that Pma1 is the major consumer of ATP in the cell and is thought to consume 20 to 50% of the cellular ATP (34).”
BackgroundAndrés, M. T., Acosta-Zaldívar, M., & Fierro, J. F. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03130-15 · Cited by 41
Factors and processes involved in membrane potential build-up in yeast: diS-C3(3) assay
Gášková, D., Brodská, B., Holoubek, A., & Sigler, K. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00002-3 · Cited by 38 · cited 1×
“To our knowledge, DMM-11, a competitive inhibitor of Mg2 -ATP, is the only other Pma1 inhibitor which has previously been shown to depolarize the fungal plasma membrane (12).”
BackgroundBillack, B., Piętka-Ottlik, M., Santoro, M., Nicholson, S., Młochowski, J., & Lau-Cam, C. (2010) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903179419 · Cited by 35
Kongstad, K. T., Wubshet, S. G., Johannesen, A., Kjellerup, L., Winther, A.-M. L., Jäger, A. K., & Stærk, D. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501605z · Cited by 32 · cited 1×
“Natural products, such as tellimagrandin II (16) and the immunoprotein lactoferrin”
BackgroundSelf-citationTaltavull, J., Serrat, J., Gràcia, J., Gavaldà, A., Andrés, M., Córdoba, M., Miralpeix, M., Vilella, D., Beleta, J., Ryder, H., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100524j · Cited by 31
Mechanism of the inhibition of hog gastric H+,K(+)-ATPase by the seleno-organic compound ebselen.
Tabuchi, Y., Ogasawara, T., & Furuhama, K. (1994) · PubMed · Cited by 29
Orie, N. N., Warren, A. R., Basaric, J., Lau‐Cam, C. A., Pįętka-Ottlik, M., Młochowski, J., & Billack, B. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21892 · Cited by 28 · cited 1×
“albicans was found to be 11 M, in agreement with the previously reported value of 14 M (18).”
ResultStevens, H. C., & Nichols, J. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700454200 · Cited by 27 · cited 1×
“Increased iATP levels have also been observed in Pma1 mutants with partial defects in pumping activity (35), supporting the hypothesis that increased iATP levels are a consequence of Pma1 inhibition.”
BackgroundDemethoxycurcumin Is A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life
Dao, T. T., Sehgal, P., Tung, T. T., Møller, J. V., Nielsen, J., Palmgren, M., Christensen, S. B., & Fuglsang, A. T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163260 · Cited by 25
Self-citationSirakanyan, S. N., Овакимян, А. А., Noravyan, A. S., Minasyan, N. S., Dzhagatspanyan, I. A., Nazaryan, I. M., & Akopyan, A. G. (2014) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-014-1026-6 · Cited by 19
Paronikyan, E. G., Noravyan, A. S., Акопян, Ш. Ф., Dzhagatspanyan, I. A., Nazaryan, I. M., & Paronikyan, R. G. (2007) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-007-0102-6 · Cited by 15
Synthesis and Neurotropic Activity of New Pyrimido[4′,5′:4,5]Thieno[2,3-b]Quinoline Derivatives
Дабаева, В. В., Bagdasaryan, M. R., Noravyan, A. S., Dzhagatspanyan, I. A., Nazaryan, I. M., & Akopyan, A. G. (2015) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-015-1334-5 · Cited by 13
David-Bosne, S., Florent, I., Winther, A.-M. L., Hansen, J. B., Buch-Pedersen, M. J., Machillot, P., le Maire, M., & Jaxel, C. (2013) · FEBS Journal · doi:10.1111/febs.12244 · Cited by 11 · cited 1×
“Given that ebselen has previously been reported to inhibit PfATP6 and the H ,K -ATPase (13, 14), this compound is likely an unspecific P-type ATPase inhibitor.”
BackgroundSelf-citationPlášek, J., & Gášková, D. (2013) · Journal of Fluorescence · doi:10.1007/s10895-013-1323-6 · Cited by 10 · cited 1×
“Previously, DiBAC4(3) (30) and other fluorescent probes used to measure membrane potential, such as 3,3-dipropylthiacarbocyanide iodide) [diS-C3(3)] (31), have been used to estimate changes in membrane potential.”
Paronikyan, E. G., Dashyan, S. S., Noravyan, A. S., Dzhagatspanyan, I. A., Paronikyan, R. G., Nazaryan, I. M., & Akopyan, A. G. (2016) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-016-1440-z · Cited by 10 · cited 1×
“Additionally, diverse biological activities, such as anticonvulsant (25–27) and neurotropic (28, 29) activities, have been ascribed to compounds similar to those presented here.”
BackgroundDashyan, S. S., Paronikyan, E. G., Noravyan, A. S., & Paronikyan, R. G. (2016) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-016-1426-x · Cited by 4
Research works printed but not linked: 1
- Shah T SinghN GoyalR DevA ChhabriaM ShishooC. 1995. Pharmacological evaluation of LM-2616: a beta1-adrenoceptor antagonist with beta2-adrenoceptor agonistic activity. Pharmacol Commun5:253–266.
Cited by
Structure and activation mechanism of the hexameric plasma membrane H+-ATPase
Zhao, P., Zhao, C., Chen, D., Yun, C., Li, H., & Bai, L. (2021) · Nature Communications · doi:10.1038/s41467-021-26782-y · Cited by 86
Taveira, G. B., Mello, É. D. O., de Souza, S. B., Monteiro, R. M., Ramos, A. C., Carvalho, A. D. O., Rodrigues, R., Okorokov, L. A., & Gomes, V. M. (2018) · Bioscience Reports · doi:10.1042/bsr20180119 · Cited by 47
Marchesini, M., Gherli, A., Montanaro, A., Patrizi, L., Sorrentino, C., Pagliaro, L., Rompietti, C., Kitara, S., Heit, S., Olesen, C., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.04.002 · Cited by 46
“To identify potent P-type ATPase inhibitors in this context, Kjellerup and colleagues screened a library containing nearly 191 000 compounds for inhibition of the fungal H+ATPase (Kjellerup et al., 2017).”
BackgroundInfluentialSelf-citationCohrt, K. A. O., Marín, L., Kjellerup, L., Clausen, J. D., Dalby-Brown, W., Calera, J. A., & Winther, A.-M. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02024-17 · Cited by 32
Self-citationElucidation of antimicrobial activity and mechanism of action by N-substituted carbazole derivatives
Clausen, J. D., Kjellerup, L., Cohrt, K. O., Hansen, J. B., Dalby‐Brown, W., & Winther, A.-M. L. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.067 · Cited by 32
Self-citation
Metadata
- Authors
- Kjellerup, L., Gordon, S., Cohrt, K. O., Brown, W. D., Fuglsang, A. T., & Winther, A.-M. L.
- Affiliations
- University of Copenhagen (DK)
- Pcovery, Copenhagen, Denmark
- Corresponding author
- Kjellerup, Lasse
- Winther, Anne-Marie L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2017-07
- Volume
- 61
- Issue
- 7
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC5487681
- OpenAlex
- W2610144401
- Cited by
- 50
- References
- 35
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 2
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- Funders
- Innovation Fund Denmark (4019-00019B)
- Wellcome (100480/Z/12)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Keywords
- Pma1, plasma membrane H+-ATPase, antifungal drug targets, Saccharomyces cerevisiae, membrane depolarization, plasma membrane potential, extracellular acidification, intracellular ATP, fungal membrane disruption, small molecule screening, antifungal drug development
- MeSH terms
- Antifungal Agents, Cell Membrane, Proton-Translocating ATPases, Humans, Membrane Potentials, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.